Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2024-09-23 00:00:00 ET · period of report 2024-09-21 · accession 0001517026-24-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-23 | 2024-09-21 | MYGN | Verratti Mark | Chief Commercial Off | F - Tax | $27.64 | -1,075 | 297.6K | -0.4% | -$29.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-21 | F | D | 1,075 | $27.64 | 297,640 | D | — | — |